Profile | GDS5420 / 214253_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 318.16 | 60 |
GSM1296119 | B_lesional_pre-dose | 90.91 | 38 |
GSM1296076 | C_lesional_pre-dose | 38.42 | 26 |
GSM1296092 | D_lesional_pre-dose | 98.06 | 43 |
GSM1296103 | E_lesional_pre-dose | 286.9 | 58 |
GSM1296078 | F_lesional_pre-dose | ||
GSM1296107 | G_lesional_pre-dose | 114.15 | 42 |
GSM1296109 | H_lesional_pre-dose | 204.51 | 51 |
GSM1296080 | I_lesional_pre-dose | 205.64 | 54 |
GSM1296090 | J_lesional_pre-dose | 34.46 | 27 |
GSM1296074 | K_lesional_pre-dose | 131.66 | 48 |
GSM1296111 | L_lesional_pre-dose | 100.87 | 39 |
GSM1296099 | M_lesional_pre-dose | 261.03 | 56 |
GSM1296086 | O_lesional_pre-dose | 51.58 | 33 |
GSM1296117 | P_lesional_pre-dose | 116.88 | 42 |
GSM1296113 | Q_lesional_pre-dose | 108.75 | 39 |
GSM1296096 | R_lesional_pre-dose | 202.95 | 53 |
GSM1296105 | S_lesional_pre-dose | 269.87 | 57 |
GSM1296098 | T_lesional_pre-dose | 370.9 | 62 |
GSM1296101 | U_lesional_pre-dose | 290.05 | 58 |
GSM1296121 | V_lesional_pre-dose | 61.79 | 33 |
GSM1296088 | W_lesional_pre-dose | 61.46 | 35 |
GSM1296082 | X_lesional_pre-dose | ||
GSM1296115 | Y_lesional_pre-dose | 154.64 | 47 |
GSM1296084 | Z_lesional_pre-dose | 90.3 | 40 |
GSM1296072 | B_lesional_day8 | 112.29 | 42 |
GSM1296069 | L_lesional_day8 | 138.65 | 44 |
GSM1296071 | P_lesional_day8 | 163.77 | 47 |
GSM1296070 | Y_lesional_day8 | 101.37 | 39 |
GSM1296073 | V_lesional_day8 | 86.41 | 38 |
GSM1296034 | A_lesional_day15 | 504.79 | 67 |
GSM1296041 | G_lesional_day15 | 11.2 | 9 |
GSM1296035 | R_lesional_day15 | 233.75 | 55 |
GSM1296038 | U_lesional_day15 | 87.78 | 39 |
GSM1296047 | B_lesional_day15 | 128.51 | 44 |
GSM1296039 | E_lesional_day15 | 115.63 | 44 |
GSM1296042 | H_lesional_day15 | 7.16 | 5 |
GSM1296043 | L_lesional_day15 | 119.94 | 41 |
GSM1296037 | M_lesional_day15 | 494.66 | 67 |
GSM1296046 | P_lesional_day15 | 168.8 | 48 |
GSM1296044 | Q_lesional_day15 | 105.94 | 39 |
GSM1296045 | Y_lesional_day15 | 134.54 | 43 |
GSM1296025 | C_lesional_day15 | 167.62 | 50 |
GSM1296033 | D_lesional_day15 | 121.91 | 45 |
GSM1296027 | I_lesional_day15 | 126.81 | 47 |
GSM1296032 | J_lesional_day15 | 171.89 | 50 |
GSM1296024 | K_lesional_day15 | 204.5 | 53 |
GSM1296031 | W_lesional_day15 | 127.36 | 44 |
GSM1296028 | X_lesional_day15 | 124.74 | 45 |
GSM1296029 | Z_lesional_day15 | 123.76 | 45 |
GSM1296026 | F_lesional_day15 | 56.31 | 33 |
GSM1296030 | O_lesional_day15 | 69.34 | 39 |
GSM1296040 | S_lesional_day15 | 324.29 | 60 |
GSM1296036 | T_lesional_day15 | 291.21 | 58 |
GSM1296048 | V_lesional_day15 | 93.19 | 39 |
GSM1296059 | A_lesional_day43 | 322.74 | 60 |
GSM1296066 | G_lesional_day43 | 23.69 | 17 |
GSM1296060 | R_lesional_day43 | 143.56 | 47 |
GSM1296063 | U_lesional_day43 | 52.34 | 31 |
GSM1296064 | E_lesional_day43 | 92.57 | 41 |
GSM1296067 | H_lesional_day43 | 94.15 | 38 |
GSM1296062 | M_lesional_day43 | 456.46 | 66 |
GSM1296068 | Q_lesional_day43 | 187.9 | 49 |
GSM1296050 | C_lesional_day43 | 54.84 | 31 |
GSM1296057 | D_lesional_day43 | 321.32 | 60 |
GSM1296052 | I_lesional_day43 | 119.54 | 46 |
GSM1296054 | J_lesional_day43 | 172.71 | 49 |
GSM1296049 | K_lesional_day43 | 158.73 | 49 |
GSM1296055 | W_lesional_day43 | 175.29 | 49 |
GSM1296053 | X_lesional_day43 | 142.75 | 47 |
GSM1296058 | Z_lesional_day43 | 112.69 | 44 |
GSM1296051 | F_lesional_day43 | 77.1 | 38 |
GSM1296056 | O_lesional_day43 | 78.57 | 39 |
GSM1296065 | S_lesional_day43 | 46.06 | 29 |
GSM1296061 | T_lesional_day43 | 454.81 | 65 |
GSM1296095 | A_non-lesional_pre-dose | 96.12 | 41 |
GSM1296120 | B_non-lesional_pre-dose | 89.14 | 37 |
GSM1296077 | C_non-lesional_pre-dose | 124.77 | 46 |
GSM1296093 | D_non-lesional_pre-dose | 254.05 | 55 |
GSM1296104 | E_non-lesional_pre-dose | 189.4 | 51 |
GSM1296079 | F_non-lesional_pre-dose | 109.47 | 43 |
GSM1296108 | G_non-lesional_pre-dose | 114.13 | 42 |
GSM1296110 | H_non-lesional_pre-dose | 63.24 | 31 |
GSM1296081 | I_non-lesional_pre-dose | 83.97 | 40 |
GSM1296091 | J_non-lesional_pre-dose | 29.28 | 24 |
GSM1296075 | K_non-lesional_pre-dose | 88.53 | 40 |
GSM1296112 | L_non-lesional_pre-dose | 201.1 | 50 |
GSM1296100 | M_non-lesional_pre-dose | 527.16 | 68 |
GSM1296087 | O_non-lesional_pre-dose | 62.25 | 37 |
GSM1296118 | P_non-lesional_pre-dose | 232.75 | 53 |
GSM1296114 | Q_non-lesional_pre-dose | 118.06 | 41 |
GSM1296097 | R_non-lesional_pre-dose | 134.12 | 46 |
GSM1296106 | S_non-lesional_pre-dose | 242.75 | 55 |
GSM1296102 | U_non-lesional_pre-dose | 289.72 | 57 |
GSM1296122 | V_non-lesional_pre-dose | 139.43 | 45 |
GSM1296089 | W_non-lesional_pre-dose | 83.52 | 37 |
GSM1296083 | X_non-lesional_pre-dose | 189.91 | 51 |
GSM1296116 | Y_non-lesional_pre-dose | 22.16 | 15 |
GSM1296085 | Z_non-lesional_pre-dose | 185.44 | 51 |